Showing 891-900 of 964 results for "".
- ASDS Issues New Recommendations on Preventing and Treating Filler Complicationshttps://modernaesthetics.com/news/asds-issues-new-recommendations-on-preventing-and-treating-filler-complications/2473060/The American Society for Dermatologic Surgery (ASDS) Multispecialty Soft-tissue Fillers Guideline Task Force has
- Pulse Biosciences Gets FDA Clearance for CellFXhttps://modernaesthetics.com/news/pulse-biosciences-gets-fda-clearance-for-cellfx/2473058/The FDA has cleared the CellFX® System from Pulse Biosciences, Inc. for dermatologic procedures requiring ablation and resurfacing of the skin, and a controlled commercial launch will soon beginning in the US with a of select group of leaders in aesthetic dermatology. The
- Are COVID-19 Vaccines Safe for Filler Patients?https://modernaesthetics.com/news/facial-fillers-and-covid-19-vaccines-is-there-a-risk-for-adverse-reactions/2473036/Three patients with dermal fillers have had adverse reactions to the Moderna COVID-19 vaccine, according to the Aesthetic Society. The FDA intends to note this in its prescribing information. There have been no reported cases in patients receiving the Pfizer COVID-19 vaccine.
- Revance Therapeutics and Ajinomoto Bio-Pharma Services Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injectionhttps://modernaesthetics.com/news/revance-therapeutics-and-ajinomoto-bio-pharma-services-announce-manufacturing-agreement-for-supply-of-daxibotulinumtoxina-for-injection/2473035/Ajinomoto Bio-Pharma Services will serve as a supply source and provide manufacturing for Revance Therapeutics, Inc.’s DaxibotulinumtoxinA for Injection. DaxibotulinumtoxinA for Injection is currently under Biologics License Application (BLA) review.
- Expert Sets Record Straight on COVID-19 Vaccine/Fillers “Risk”https://modernaesthetics.com/news/expert-sets-record-straight-on-covid-19-vaccinefillers-risk/2473033/When FDA officials reviewed the data for Moderna’s COVID-19 vaccine, a data point garnered some attention. There seemed to be at least a temporal association between treatment with dermal fillers and non-serious adverse reactions to the vaccine in three study subjects. Modern Aesth
- ISAPS Reports Continuing Rise in Aesthetic Surgery Worldwidehttps://modernaesthetics.com/news/isaps-reports-continuing-rise-in-aesthetic-surgery-worldwide/2473026/Total surgical and nonsurgical cosmetic procedures increased by 7.4 percent in 2019, according to the International Society of Aesthetic Plastic Surgery (ISAPS) 2019 Global Survey. The 7.4 perce
- Gwyneth Paltrow Named Global Face of Xeominhttps://modernaesthetics.com/news/gwyneth-paltrow-named-global-face-of-xeomin-1/2472991/Actress and Goop wellness guru Gwyneth Paltrow is the first global face of Merz Aesthetic’s Xeomin. In this role, Paltrow will be sharing details about what she does to look and feel her best, and will ask women to do the same on social media using #DareToSelfCare. &ldqu
- Amore Pacific Gets Woke with Enough Project Lifestyle Brandhttps://modernaesthetics.com/news/amore-pacific-gets-woke-with-enough-project-lifestyle-brand/2472983/South Korea’s Amorepacific is launching its newest vegan-friendly lifestyle brand: Enough Project. This new brand is vegan-friendly, involves no animal testing, and contains no animal ingredients. In a
- Abbvie’s Allergan: 1, Evolus: O in First Round of Trade Disputehttps://modernaesthetics.com/news/abbvies-allergan-1-evolus-o-in-first-round-of-trade-dispute/2472962/Evolus' and Daewoong Pharma's Jeuveau lost the first round in a trade dispute with AbbVie's Allergan and its Korean partner Medytox that sought to block imports of the Botox rival, but the match is not over yet. AbbVie's Allergan and its Korean partner Medytox
- CE Mark Plus Launch for System ONE-M from TOOsonix A/Shttps://modernaesthetics.com/news/ce-mark-plus-launch-for-system-one-m-from-toosonix-as/2472959/TOOsonix A/S is launching its CE-marked System ONE-M for color-independent tattoo removal, solar lentigines, spider veins, angiomas, telangiectasia and other aesthetic conditions. System ONE-M is a focused ultr